NEW YORK, May 2 - Structural proteomics company Syrrx will provide high-throughput protein crystallization and protein-structure analysis for Roche, the company said today.
Syrrx will get an up-front technology access fee from the pharmaceutical company. The company may also be entitled to milestone payments, success payment, and license fees.
The firms did not reveal which proteins or therapeutic indications the arrangement covers.
Click here for more information.